Appendix 3Y
Change of Director's Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director's Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity
ABN
Ramsay Health Care Limited 57 001 288 768
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Karen Penrose |
Date of last notice | 3 September 2021 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.
Direct or indirect interest | Direct interest - see below Indirect interest - no change |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | N/A |
Date of change | 29 April 2022 |
No. of securities held prior to change | Direct interest -580 Share Rights acquired by way of salary sacrifice under the Non-Executive Director Share Rights Plan Indirect interest -957 ordinary shares held indirectly through GKP Acquisitions Pty Ltd as trustee for the Karen Lee Super Fund |
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y
Change of Director's Interest Notice
Class | Ordinary shares |
Number acquired | 580 ordinary shares |
Number disposed | Nil |
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | $68.9588 average price per share (calculated using the VWAP of company shares traded on the ASX over the 5 trading day period commencing on the trading day after the FY21 preliminary full year results are released to the market, in accordance with the terms of the Ramsay Non-Executive Director Share Rights Plan) |
No. of securities held after change | Direct interest -580 ordinary shares Indirect interest -957 ordinary shares held indirectly through GKP Acquisitions Pty Ltd as trustee for the Karen Lee Super Fund |
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | Restricted Shares acquired following the vesting of Share Rights granted in 2021 under the terms of the Non-Executive Director Share Rights Plan by way of salary sacrifice of director fees, as approved by shareholders at the Annual General Meeting held on 24 November 2020. |
Part 2 - Change of director's interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.
Detail of contract | N/A |
Nature of interest | N/A |
Name of registered holder (if issued securities) | N/A |
Date of change | N/A |
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y
Change of Director's Interest Notice
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | N/A |
Interest acquired | N/A |
Interest disposed | N/A |
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | N/A |
Interest after change | N/A |
Part 3 - +Closed period
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
If so, was prior written clearance provided to allow the trade to proceed during this period? | N/A |
If prior written clearance was provided, on what date was this provided? | N/A |
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Ramsay Health Care Limited published this content on 29 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 April 2022 03:41:04 UTC.